MedPath

Ethanol

Generic Name
Ethanol
Brand Names
Dalmacol, Gattex, Healing Waters Aloe Cucumber Hand Sanitizer, Healing Waters Cotton Blossom Hand Sanitizer, Healing Waters Lemon Verbena Hand Sanitizer, Healing Waters Peach Nectarine Hand Sanitizer, Lupaneta Pack 1-month, Viva-drops Lubricating Eye Drops
Drug Type
Small Molecule
Chemical Formula
C2H6O
CAS Number
64-17-5
Unique Ingredient Identifier
3K9958V90M
Background

A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages.

Indication

For therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated.

Associated Conditions
Bacterial Infections, Obstructive Hypertrophic Cardiomyopathy, Skin Irritation, Bacterial skin infections, Ethylene glycol overdose, Fat occlusion in central venous catheter, Methanol overdose
Associated Therapies
Hand Hygiene, Skin disinfection
Clinical Trials
Related News

Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations

Early Phase 1
Active, not recruiting
Conditions
Marijuana Impairment
Alcohol Impairment
Interventions
Drug: Low Marijuana, Hash, THC, or Grass
Drug: High Marijuana, Hash, THC, or Grass
Drug: Placebo
First Posted Date
2021-04-23
Last Posted Date
2024-07-23
Lead Sponsor
Yale University
Target Recruit Count
12
Registration Number
NCT04856566
Locations
🇺🇸

Hartford Hospital, Hartford, Connecticut, United States

EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy

Phase 4
Conditions
Pancreatic Neoplasms
Pain
Cancer of Pancreas
Pain Management
Cancer-Associated Pain
Interventions
Device: 19G EUSRA needle, Taewoong Medical, Korea
First Posted Date
2021-03-22
Last Posted Date
2021-03-22
Lead Sponsor
The University of Hong Kong
Target Recruit Count
54
Registration Number
NCT04809935
Locations
🇭🇰

Queen Mary Hospital, Hong Kong, Hong Kong

Endoscopic Ultrasound Guided Coeliac Plexus Neurolysis for Cancer Pain

Phase 4
Not yet recruiting
Conditions
Malignancy
Pain Management
Interventions
Device: Radiofrequency Ablation
First Posted Date
2021-03-16
Last Posted Date
2021-03-22
Lead Sponsor
The University of Hong Kong
Target Recruit Count
54
Registration Number
NCT04801082
Locations
🇭🇰

The University of Hong Kong, Hong Kong, Hong Kong

The Effect of Using 70% Ethanol Alcohol as a Root Canal Irrigant on Increasing the Success Rate of Metapex in Pulpectomy Compared to Normal Saline in Primary Molars

Early Phase 1
Conditions
Mobility, Tooth
Pain
Resorption, Root
Pulpitis - Irreversible
Abscess Bone
Interventions
First Posted Date
2020-12-16
Last Posted Date
2021-07-29
Lead Sponsor
Cairo University
Target Recruit Count
20
Registration Number
NCT04669392

Estradiol Effects on Alcohol Across the Menstrual Cycle

Not Applicable
Completed
Conditions
Alcohol Use, Unspecified
Interventions
Drug: Placebo
First Posted Date
2020-10-20
Last Posted Date
2025-01-10
Lead Sponsor
Mark Fillmore
Target Recruit Count
100
Registration Number
NCT04595682
Locations
🇺🇸

University Of Kentucky Psychology Research Lab, Lexington, Kentucky, United States

Mouth Rinses for Inactivation of COVID-19

Phase 2
Terminated
Conditions
Covid19
Coronavirus Infection
SARS-CoV-2 Infection
Interventions
Other: 0.9% w/v NaCL Saline
Drug: 0.5% w/v Povidone-iodide
Drug: 0.12% Chlorohexidine Gluconate
First Posted Date
2020-10-14
Last Posted Date
2024-03-25
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
128
Registration Number
NCT04584684
Locations
🇺🇸

General and Oral Health Center, Chapel Hill, North Carolina, United States

New Treatment for COVID-19 Using Ethanol Vapor Inhalation .

Phase 3
Conditions
Covid-19
Drug Effect
Interventions
First Posted Date
2020-09-18
Last Posted Date
2020-10-28
Lead Sponsor
Mansoura University
Target Recruit Count
80
Registration Number
NCT04554433

Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma

Completed
Conditions
Hepatocellular Carcinoma
Interventions
Device: Radiofrequency ablation
Drug: Trance-arterial chemoembolization
Procedure: Liver resection
Combination Product: Combined radiofrequency ablation + percutaneous ethanol injection
Drug: Systemic chemotherapy
Dietary Supplement: Viscum
Drug: Symptomatic treatment
First Posted Date
2020-09-17
Last Posted Date
2020-09-17
Lead Sponsor
Sohag University
Target Recruit Count
407
Registration Number
NCT04553458

Sex Differences in Risk for Alcohol Abuse

Not Applicable
Completed
Conditions
Alcohol Abuse
Interventions
Drug: Saline
First Posted Date
2020-09-10
Last Posted Date
2023-08-28
Lead Sponsor
Mark Fillmore
Target Recruit Count
22
Registration Number
NCT04543942
Locations
🇺🇸

University Of Kentucky Psychology Research Lab, Lexington, Kentucky, United States

Alcohol and Opioids

Phase 1
Completed
Conditions
Opioid Use
Alcohol Drinking
Interventions
Drug: Opioid Agonist
First Posted Date
2020-03-09
Last Posted Date
2024-12-11
Lead Sponsor
Sharon Walsh
Target Recruit Count
10
Registration Number
NCT04300751
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy